Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

CG Oncology has the lowest figure of the 24 biotech companies ranked by cash on hand, at CHF 27.4M, followed by Adaptive Biotechnologies (CHF 59.5M) and ImmunityBio (CHF 74.5M). Figures as of 18 Nov 2026, 23:32 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
CG OncologyCHF 27.4M
Median
CHF 365.3M
Combined market value
CHF 705.5B
Countries
5

Market values as of .

All countries
All sectors
Biotech
CHF
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↑Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health CareCHF 27.4MCHF 6BCHF 67.48 1.34% up 85% up United States
2Adaptive BiotechnologiesADPT · Health CareCHF 59.5MCHF 3.9BCHF 24.01 0.11% down 88% up United States
3ImmunityBioIBRX · Health CareCHF 74.5MCHF 6BCHF 5.65 7.03% up 193% up United States
4Halozyme TherapeuticsHALO · Health CareCHF 112.9MCHF 9.2BCHF 80.81 0.18% down 37% up United States
5VaxcytePCVX · Health CareCHF 146.7MCHF 7.8BCHF 49.36 1.48% down 22% up United States
6Twist BioscienceTWST · Health CareCHF 154.4MCHF 6.7BCHF 98.14 3.88% up 340% up United States
7Kodiak SciencesKOD · Health CareCHF 177MCHF 5.4BCHF 82.50 1.04% up 396% up United States
8Bio-TechneTECH · Health CareCHF 223.3MCHF 9.6BCHF 61.36 0.17% up 26% up United States
9Scholar Rock HoldingSRRK · Health CareCHF 272.9MCHF 4.9BCHF 40.49 6.48% up 14% up United States
10CRISPR TherapeuticsCRSP · Health CareCHF 293.2MCHF 3.3BCHF 33.90 0.10% up 21% down Switzerland
11Kymera TherapeuticsKYMR · Health CareCHF 301.1MCHF 8.7BCHF 102.17 0.32% down 87% up United States
12Revolution MedicinesRVMD · Health CareCHF 323.7MCHF 29.2BCHF 134.81 1.76% down 131% up United States
13ExelixisEXEL · Health CareCHF 407MCHF 14.1BCHF 57.60 0.31% down 63% up United States
14Krystal BiotechKRYS · Health CareCHF 418.6MCHF 7.9BCHF 265.99 5.62% up 46% up United States
15RepligenRGEN · Health CareCHF 477.4MCHF 9.3BCHF 145.65 6.47% up 5% up United States
16Neurocrine BiosciencesNBIX · Health CareCHF 601.4MCHF 13.9BCHF 137.37 1.84% down 20% up United States
17QiagenQGEN · Health CareCHF 707.7MCHF 8.6BCHF 41.80 0.38% down 12% up Netherlands
18ImmunovantIMVT · Health CareCHF 760.9MCHF 5.8BCHF 27.98 0.12% down 43% up United States
19ModernaMRNA · Health CareCHF 2.2BCHF 67.2BCHF 165.99 4.84% down 755% up United States
20BiogenBIIB · Health CareCHF 2.5BCHF 31.3BCHF 212.06 0.25% up 49% up United States
21argenxARGX · Health CareCHF 2.9BCHF 49.9BCHF 793.93 0.66% down 4% up Belgium
22Gilead SciencesGILD · Health CareCHF 6.4BCHF 176.8BCHF 142.53 0.75% down 33% up United States
23BioNTechBNTX · Health CareCHF 7.2BCHF 17.4BCHF 70.23 1.89% down 16% down Germany
24AmgenAMGN · Health CareCHF 7.7BCHF 202.5BCHF 374.42 3.07% down 34% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8435 CHF).

Questions and answers

Which biotech companies have the lowest cash on hand?

CG Oncology (CHF 27.4M), Adaptive Biotechnologies (CHF 59.5M) and ImmunityBio (CHF 74.5M) have the lowest cash on hand of the 24 biotech companies ranked here as of 18 Nov 2026, 23:32 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of CHF 705.5B as of 18 Nov 2026, 23:32 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.